NCT07396740

Brief Summary

This study aims to describe the cellular and non-cellular components of different types of benign and malignant tumors.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,000

participants targeted

Target at P75+ for all trials

Timeline
39mo left

Started Sep 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Sep 2024Jul 2029

First Submitted

Initial submission to the registry

September 18, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

September 18, 2024

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2029

Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

4.9 years

First QC Date

September 18, 2024

Last Update Submit

February 4, 2026

Conditions

CancerBenign Tumors

Outcome Measures

Primary Outcomes (2)

  • Composition of the stroma

    Numbers of non tumor cells per mm²

    5 years

  • Composition of the stroma

    Percentages of matrix within tissu areas

    5 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

any patient with pathological sample analyzed in Brest UH since 2000

You may qualify if:

  • any patient with pathological sample analyzed in Brest UH since 2000

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2024

First Posted

February 9, 2026

Study Start

September 18, 2024

Primary Completion (Estimated)

July 31, 2029

Study Completion (Estimated)

July 31, 2029

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning three years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations

FR(1)